MITSUBISHI TANABE PHARMA CORPORATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 113144
 
  
 
C07D HETEROCYCLIC COMPOUNDS 8583
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2228
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 2075
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1386
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 13154
 
  
 
C07K PEPTIDES 11125
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 10128
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 495
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0283,494 HUMAN ANTI-IL-33 NEUTRALIZING MONOCLONAL ANTIBODYJun 13, 17Oct 05, 17[A61K, C07K]
2016/0108,078 GLUCOPYRANOSIDE COMPOUNDDec 28, 15Apr 21, 16[C07H]
2016/0002,276 METHOD FOR PRODUCING a-HALO-TETRAACYL-GLUCOSEFeb 25, 14Jan 07, 16[C07H]
2015/0216,961 ROTAVIRUS-LIKE PARTICLE PRODUCTION IN PLANTSMay 10, 13Aug 06, 15[A61K, C12N, C07K]
2014/0228,420 PHARMACEUTICAL AGENT FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS OR SUPPRESSING DISEASE PROGRESS THEREOFSep 05, 12Aug 14, 14[A61K]
2014/0121,240 NOVEL PHARMACEUTICAL COMPOSITIONJun 26, 12May 01, 14[C07D]
2012/0323,178 BEPOTASTINE COMPOSITIONSJan 03, 12Dec 20, 12[A61K, A61P, A61M]
2012/0255,544 BEPOTASTINE COMPOSITIONSMay 02, 12Oct 11, 12[A61K, A61P, A61M]
2012/0225,905 BEPOTASTINE COMPOSITIONSMay 02, 12Sep 06, 12[A61K, A61P]
2011/0229,570 ORALLY RAPIDLY DISINTEGRATING TABLET AND PROCESS FOR PRODUCING SAMENov 25, 09Sep 22, 11[A61K, B29C, A61P]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9783522 2-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereofApr 24, 15Oct 10, 17[A61K, C07D]
9758578 Human anti-IL-33 neutralizing monoclonal antibodyDec 26, 14Sep 12, 17[A61K, C07K]
9751846 Method for producing 1,4-benzoxazine compoundJul 08, 16Sep 05, 17[C07D]
9751938 Method of inhibiting activation of a T cell by administering an anti-RGM antibody or an RGM siRNAMay 09, 16Sep 05, 17[A61K, C12N, C07K]
9753040 Polynucleotide construct capable of displaying fab in a cell-free translation system, and method for manufacturing and screening fab using sameNov 30, 11Sep 05, 17[C12N, G01N, C07K]
9725508 Human anti-IL-33 neutralizing monoclonal antibodyDec 26, 14Aug 08, 17[A61K, C07K]
9655852 Tablets containing a 1-(β-D-glucopyranosyl)-3-(phenylthienylmethyl)benzene compoundApr 20, 16May 23, 17[A61K]
9657043 Amine compound and use thereof for medical purposesApr 23, 13May 23, 17[A61K, C07F, C07D, C07C]
9643920 Crystalline 4-(3S-(1R-(1-napthyl)ethylamino)pyrrolidin-1-yl)phenylacetic acidSep 05, 14May 09, 17[C07D]
9572806 Elution-stabilized preparationDec 17, 10Feb 21, 17[A61K, A61P]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2018/0017,573 POLYNUCLEOTIDE CONSTRUCT CAPABLE OF DISPLAYING FAB IN A CELL-FREE TRANSLATION SYSTEM, AND METHOD FOR MANUFACTURING AND SCREENING FAB USING SAMEAbandonedSep 01, 17Jan 18, 18[C12N, G01N, C07K]
2015/0239,889 PYRAZOLOPYRIMIDINE COMPOUNDAbandonedAug 22, 13Aug 27, 15[C07D]
2015/0182,602 PHARMACEUTICAL FORMULATIONS COMPRISING PARAOXONASEAbandonedMar 09, 15Jul 02, 15[A61K]
2015/0104,483 THERAPEUTIC AGENT FOR CEREBRAL INFARCTIONAbandonedDec 18, 14Apr 16, 15[C07D]
2014/0371,162 COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORSAbandonedAug 28, 14Dec 18, 14[A61K]
2014/0350,249 THERAPEUTIC AGENT FOR CEREBRAL INFARCTIONAbandonedAug 12, 14Nov 27, 14[C07D]
2014/0350,250 THERAPEUTIC AGENT FOR CEREBRAL INFARCTIONAbandonedAug 12, 14Nov 27, 14[C07D]
2014/0296,506 GLUCOPYRANOSIDE COMPOUNDAbandonedJun 09, 14Oct 02, 14[C07H]
8748620 Thyroid hormone β receptor agonistWithdrawnApr 19, 10Jun 10, 14[A61K, C07D]
2014/0073,671 ORALLY DISINTEGRATING TABLETAbandonedApr 20, 12Mar 13, 14[A61K]
8592417 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhibitorsExpiredDec 26, 07Nov 26, 13[A61K, C07D]
8575338 Pyrimidine, pyridine and triazine derivatives as maxi-K channel openersExpiredApr 08, 09Nov 05, 13[A61K, C07D, A61P]
8569294 2-(cyclic amino)-pyrimidone derivativesExpiredMar 14, 07Oct 29, 13[A61K]
8530506 Process for production of biphenyl derivativeExpiredSep 24, 10Sep 10, 13[A61K, C07D]
8524212 Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitisExpiredApr 22, 08Sep 03, 13[A61K, A61P]
8501809 mediated cell adhesionExpiredDec 08, 10Aug 06, 13[A61K, C07C]
8497382 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereofExpiredDec 01, 09Jul 30, 13[A61K, C07D]
8492145 Process for producing nerve cellsExpiredJun 23, 03Jul 23, 13[C12N]
8471032 Benzimidazole compound in crystal form and salt thereofExpiredSep 16, 09Jun 25, 13[C07D]
2013/0072,477 TREATMENT OF PARKINSON'S DISEASE AND ENHANCEMENT OF DOPAMINE SIGNAL USING PDE 10 INHIBITORAbandonedNov 16, 12Mar 21, 13[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.